Farther Finance Advisors’s Beta Bionics BBNX Stock Holding History

Farther Finance Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.89K	Buy	521 +212	+69%	+$3.81K	﹤0.01%	4618
2026 Q2	$4.85K	Sell	309 -62	-17%	-$737	﹤0.01%	4820
2026 Q1	$3.71K	Buy	371 +79	+27%	+$1.17K	﹤0.01%	4638
2025 Q4	$8.9K	Buy	292 +2	+0.7%	+$53	﹤0.01%	3992
2025 Q3	$5.76K	Hold	290	–	–	﹤0.01%	3696
2025 Q2	$4.22K	Buy	+290	New	+$4.11K	﹤0.01%	3425

Other funds holding BBNX

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's BBNX Position: Q3 2026 in Review

Farther Finance Advisors increased its Beta Bionics (BBNX) stake by 69% in Q3 2026, buying an estimated $3.81K and bringing the position to 521 shares worth $9.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4618.

Farther Finance Advisors first reported a position in BBNX in Q2 2025 and has held it in 6 quarters since. 4 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

Farther Finance Advisors held 521 shares of Beta Bionics worth $9.89K as of Q3 2026.
Farther Finance Advisors bought 212 Beta Bionics shares in Q3 2026, an estimated $3.81K.
Beta Bionics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4618 holding.
Farther Finance Advisors first reported a position in Beta Bionics in Q2 2025 and has held it in 6 quarters since.
4 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.